Charles River Laboratories International, Inc.
US ˙ NYSE ˙ US1598641074

Introduksjon

Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Robert J Bertolini. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.

Gjennomsnittlig handelslønnsomhet

Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,

Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.

Oppdateringsfrekvens: Daglig

Se listen over de mest lønnsomme insidetraderne.

Se høyest rangerte insidere
Selskaper med rapporterte insiderposisjoner

SEC-arkiveringene indikerer at Robert J Bertolini har rapporterte beholdninger av handler i følgende selskaper:

Verdipapir Navn Siste rapporterte høydepunkter
US:CRL / Charles River Laboratories International, Inc. Director 32 802
US:BMY / Bristol-Myers Squibb Company Director 26 648
US:SGP / Schering Plough Corp Executive Vice President 0
Hvordan tolke diagrammene

De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Robert J Bertolini. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.

Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.

Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.

Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.

Internkjøp CRL / Charles River Laboratories International, Inc. - Analyse av kortsiktig fortjeneste

I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i CRL / Charles River Laboratories International, Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.

Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.

Handelsdato Ticker Innsider Rapporterte
aksjer		 Rapportert
pris		 Justerte
aksjer		 Justert
pris		 Kostpris Dager til
maks		 Pris ved
maks		 Maks
fortjeneste ($)		 Maks fortjeneste (%)
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen.

Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.

CRL / Charles River Laboratories International, Inc. Insider Trades
Internhandel CRL / Charles River Laboratories International, Inc. - Analyse av kortsiktig tap

I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i CRL / Charles River Laboratories International, Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.

Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.

Handelsdato Ticker Innsider Rapporterte
aksjer		 Rapportert
pris		 Justerte
aksjer		 Justert
pris		 Kostpris Dager til
min		 Pris ved
min		 Maks tap
unngått ($)		 Maks tap
unngått (%)
2020-05-20 CRL BERTOLINI ROBERT J 3 530 174,5787 3 530 174,5787 616 263 40 169.0000 −19 692 −3,20
2020-02-13 CRL BERTOLINI ROBERT J 7 170 170,4071 7 170 170,4071 1 221 819
2018-12-04 CRL BERTOLINI ROBERT J 100 134,1900 100 134,1900 13 419
2018-12-04 CRL BERTOLINI ROBERT J 100 134,3650 100 134,3650 13 436
2018-12-04 CRL BERTOLINI ROBERT J 100 134,4650 100 134,4650 13 446
2018-12-04 CRL BERTOLINI ROBERT J 200 134,4900 200 134,4900 26 898
2018-12-04 CRL BERTOLINI ROBERT J 100 134,5000 100 134,5000 13 450
2018-12-04 CRL BERTOLINI ROBERT J 100 135,0100 100 135,0100 13 501
2018-12-04 CRL BERTOLINI ROBERT J 100 135,0300 100 135,0300 13 503
2018-12-04 CRL BERTOLINI ROBERT J 100 135,0400 100 135,0400 13 504
2018-12-04 CRL BERTOLINI ROBERT J 100 135,0600 100 135,0600 13 506
2018-12-04 CRL BERTOLINI ROBERT J 100 135,1500 100 135,1500 13 515
2018-12-04 CRL BERTOLINI ROBERT J 100 133,1600 100 133,1600 13 316
2018-12-04 CRL BERTOLINI ROBERT J 200 133,2100 200 133,2100 26 642
2018-12-04 CRL BERTOLINI ROBERT J 200 133,2800 200 133,2800 26 656
2018-12-04 CRL BERTOLINI ROBERT J 100 133,4500 100 133,4500 13 345
2018-12-04 CRL BERTOLINI ROBERT J 400 133,4600 400 133,4600 53 384
2018-12-04 CRL BERTOLINI ROBERT J 100 133,6100 100 133,6100 13 361
2018-12-04 CRL BERTOLINI ROBERT J 100 133,6300 100 133,6300 13 363
2018-12-04 CRL BERTOLINI ROBERT J 100 133,6800 100 133,6800 13 368
2018-12-04 CRL BERTOLINI ROBERT J 100 133,8100 100 133,8100 13 381
2018-12-04 CRL BERTOLINI ROBERT J 224 133,8700 224 133,8700 29 987
2018-12-04 CRL BERTOLINI ROBERT J 103 133,8800 103 133,8800 13 790
2018-12-04 CRL BERTOLINI ROBERT J 3 133,8900 3 133,8900 402
2018-12-04 CRL BERTOLINI ROBERT J 202 133,9000 202 133,9000 27 048
2018-12-04 CRL BERTOLINI ROBERT J 100 133,9100 100 133,9100 13 391
2018-12-04 CRL BERTOLINI ROBERT J 2 133,9200 2 133,9200 268
2018-12-04 CRL BERTOLINI ROBERT J 102 133,9300 102 133,9300 13 661
2018-12-04 CRL BERTOLINI ROBERT J 2 133,9400 2 133,9400 268
2018-12-04 CRL BERTOLINI ROBERT J 2 133,9500 2 133,9500 268
2018-12-04 CRL BERTOLINI ROBERT J 100 133,9800 100 133,9800 13 398
2018-12-04 CRL BERTOLINI ROBERT J 100 133,9900 100 133,9900 13 399
2018-12-04 CRL BERTOLINI ROBERT J 300 134,0000 300 134,0000 40 200
2018-12-04 CRL BERTOLINI ROBERT J 100 134,0300 100 134,0300 13 403
2018-12-04 CRL BERTOLINI ROBERT J 100 134,0400 100 134,0400 13 404
2018-12-04 CRL BERTOLINI ROBERT J 200 134,0500 200 134,0500 26 810
2018-12-04 CRL BERTOLINI ROBERT J 100 134,0600 100 134,0600 13 406
2018-12-04 CRL BERTOLINI ROBERT J 100 134,1000 100 134,1000 13 410
2018-12-04 CRL BERTOLINI ROBERT J 100 134,1100 100 134,1100 13 411
2018-12-04 CRL BERTOLINI ROBERT J 100 134,1600 100 134,1600 13 416
2017-03-01 CRL BERTOLINI ROBERT J 87 87,2700 87 87,2700 7 592
2017-03-01 CRL BERTOLINI ROBERT J 100 87,2950 100 87,2950 8 730
2017-03-01 CRL BERTOLINI ROBERT J 200 87,3000 200 87,3000 17 460
2017-03-01 CRL BERTOLINI ROBERT J 100 87,3200 100 87,3200 8 732
2017-03-01 CRL BERTOLINI ROBERT J 100 87,3500 100 87,3500 8 735
2017-03-01 CRL BERTOLINI ROBERT J 100 87,3600 100 87,3600 8 736
2017-03-01 CRL BERTOLINI ROBERT J 100 87,3900 100 87,3900 8 739
2017-03-01 CRL BERTOLINI ROBERT J 100 87,4300 100 87,4300 8 743
2017-03-01 CRL BERTOLINI ROBERT J 100 87,4400 100 87,4400 8 744
2017-03-01 CRL BERTOLINI ROBERT J 60 87,4650 60 87,4650 5 248
2017-03-01 CRL BERTOLINI ROBERT J 300 87,4700 300 87,4700 26 241
2017-03-01 CRL BERTOLINI ROBERT J 300 87,4900 300 87,4900 26 247
2017-03-01 CRL BERTOLINI ROBERT J 100 87,5000 100 87,5000 8 750
2017-03-01 CRL BERTOLINI ROBERT J 100 87,5100 100 87,5100 8 751
2017-03-01 CRL BERTOLINI ROBERT J 40 87,5150 40 87,5150 3 501
2017-03-01 CRL BERTOLINI ROBERT J 100 87,5200 100 87,5200 8 752
2017-03-01 CRL BERTOLINI ROBERT J 900 87,5500 900 87,5500 78 795
2017-03-01 CRL BERTOLINI ROBERT J 30 87,5550 30 87,5550 2 627
2017-03-01 CRL BERTOLINI ROBERT J 400 87,5600 400 87,5600 35 024
2017-03-01 CRL BERTOLINI ROBERT J 100 87,5800 100 87,5800 8 758
2017-03-01 CRL BERTOLINI ROBERT J 100 87,5850 100 87,5850 8 758
2017-03-01 CRL BERTOLINI ROBERT J 40 87,5950 40 87,5950 3 504
2017-03-01 CRL BERTOLINI ROBERT J 141 87,6000 141 87,6000 12 352
2017-03-01 CRL BERTOLINI ROBERT J 700 87,6100 700 87,6100 61 327
2017-03-01 CRL BERTOLINI ROBERT J 19 87,6150 19 87,6150 1 665
2017-03-01 CRL BERTOLINI ROBERT J 400 87,6400 400 87,6400 35 056
2017-03-01 CRL BERTOLINI ROBERT J 41 87,6450 41 87,6450 3 593
2017-03-01 CRL BERTOLINI ROBERT J 197 87,6900 197 87,6900 17 275
2017-03-01 CRL BERTOLINI ROBERT J 200 87,7700 200 87,7700 17 554
2017-03-01 CRL BERTOLINI ROBERT J 100 87,7800 100 87,7800 8 778
2017-03-01 CRL BERTOLINI ROBERT J 200 87,9100 200 87,9100 17 582
2017-03-01 CRL BERTOLINI ROBERT J 400 87,9200 400 87,9200 35 168
2017-03-01 CRL BERTOLINI ROBERT J 200 87,9300 200 87,9300 17 586
2017-03-01 CRL BERTOLINI ROBERT J 500 87,9400 500 87,9400 43 970
2017-03-01 CRL BERTOLINI ROBERT J 100 87,9450 100 87,9450 8 794
2017-03-01 CRL BERTOLINI ROBERT J 100 87,9500 100 87,9500 8 795
2017-03-01 CRL BERTOLINI ROBERT J 200 87,9600 200 87,9600 17 592
2017-03-01 CRL BERTOLINI ROBERT J 743 87,9800 743 87,9800 65 369
2017-03-01 CRL BERTOLINI ROBERT J 100 87,9900 100 87,9900 8 799
2017-03-01 CRL BERTOLINI ROBERT J 2 726 88,0000 2 726 88,0000 239 888
2017-03-01 CRL BERTOLINI ROBERT J 100 88,0200 100 88,0200 8 802
2017-03-01 CRL BERTOLINI ROBERT J 300 88,0300 300 88,0300 26 409
2017-03-01 CRL BERTOLINI ROBERT J 165 88,0600 165 88,0600 14 530
2017-03-01 CRL BERTOLINI ROBERT J 100 88,0800 100 88,0800 8 808
2017-03-01 CRL BERTOLINI ROBERT J 100 88,1200 100 88,1200 8 812
2017-03-01 CRL BERTOLINI ROBERT J 200 88,1300 200 88,1300 17 626
2017-03-01 CRL BERTOLINI ROBERT J 1 88,1700 1 88,1700 88
2017-03-01 CRL BERTOLINI ROBERT J 100 88,2100 100 88,2100 8 821
2017-03-01 CRL BERTOLINI ROBERT J 100 88,2300 100 88,2300 8 823
2017-03-01 CRL BERTOLINI ROBERT J 100 88,2700 100 88,2700 8 827
2017-03-01 CRL BERTOLINI ROBERT J 100 88,3400 100 88,3400 8 834

Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.

CRL / Charles River Laboratories International, Inc. Insider Trades
Innsidernes handelshistorikk

Tabellen viser den komplette listen over innsidehandler gjort av Robert J Bertolini som avslørt til Securies Exchange Comission (SEC).

Fildato Transaksjonsdato Skjema Ticker Verdipapir Kode 10b5-1 Aksjer Gjenværende aksjer Prosent
endring		 Aksje
pris		 Transaksjons
verdi		 Gjenværende
verdi
2024-05-15 2024-05-13 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock 		A - Award 394 32 802 1,22 228,41 89 994 7 492 305
2024-05-15 2024-05-13 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock 		A - Award 559 32 408 1,76 228,41 127 681 7 402 311
2023-05-17 2023-05-15 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock 		A - Award 468 31 849 1,49
2023-05-17 2023-05-15 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock 		A - Award 664 31 381 2,16
2022-05-13 2022-05-11 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Stock Options (Right to Buy) 		A - Award 1 582 1 582 222,31 351 694 351 694
2022-05-13 2022-05-11 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock 		A - Award 405 30 717 1,34
2022-05-13 2022-05-11 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock 		A - Award 575 30 312 1,93
2021-05-10 2021-05-07 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Stock Options (Right to Buy) 		A - Award 1 151 1 151
2021-05-10 2021-05-07 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock 		A - Award 248 29 737 0,84
2021-05-10 2021-05-07 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock 		A - Award 355 29 489 1,22
2021-04-02 2021-03-31 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units 		A - Award 554 26 648 2,12 63,13 35 000 1 682 319
2021-02-03 2021-02-01 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units 		A - Award 3 054 26 094 13,26 62,21 190 000 1 623 312
2021-01-05 2020-12-31 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units 		A - Award 564 22 860 2,53 62,03 35 000 1 417 996
2020-10-02 2020-09-30 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units 		A - Award 581 22 128 2,69 60,29 35 000 1 334 110
2020-07-02 2020-06-30 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units 		A - Award 595 21 385 2,86 58,80 35 000 1 257 430
2020-05-21 2020-05-20 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Stock Options (Right to Buy) 		M - Exercise −3 530 0 −100,00
2020-05-21 2020-05-20 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock 		S - Sale −3 530 29 134 −10,81 174,58 −616 263 5 086 176
2020-05-21 2020-05-20 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock 		M - Exercise 3 530 32 664 12,12 52,29 184 584 1 708 001
2020-05-12 2020-05-11 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Stock Options (Right to Buy) 		A - Award 2 539 2 539
2020-05-12 2020-05-11 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock 		A - Award 518 29 134 1,81
2020-05-12 2020-05-11 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock 		A - Award 741 28 616 2,66
2020-04-02 2020-03-31 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units 		A - Award 628 20 636 3,14 55,74 35 000 1 150 224
2020-02-14 2020-02-13 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Stock Options (Right to Buy) 		M - Exercise −3 140 0 −100,00
2020-02-14 2020-02-13 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Stock Options (Right to Buy) 		M - Exercise −4 030 0 −100,00
2020-02-14 2020-02-13 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock 		S - Sale −7 170 27 875 −20,46 170,41 −1 221 819 4 750 098
2020-02-14 2020-02-13 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock 		M - Exercise 3 140 35 045 9,84 70,29 220 711 2 463 313
2020-02-14 2020-02-13 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Common Stock 		M - Exercise 4 030 31 905 14,46 43,39 174 862 1 384 358
2020-02-04 2020-02-01 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units 		A - Award 3 018 20 008 17,77 62,95 190 000 1 259 479
2020-01-03 2019-12-31 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units 		A - Award 516 16 870 3,16 64,19 33 125 1 082 882
2019-10-02 2019-09-30 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units 		A - Award 653 16 237 4,19 50,71 33 125 823 400
2019-08-01 2019-07-31 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value 		P - Purchase 11 000 11 397 2 770,78 44,72 491 920 509 674
2019-07-02 2019-06-30 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units 		A - Award 730 15 444 4,96 45,35 33 125 700 391
2019-05-23 2019-05-22 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		A - Award 657 27 875 2,41
2019-05-23 2019-05-22 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		A - Award 1 882 27 218 7,43
2019-04-02 2019-03-31 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units 		A - Award 694 14 585 5,00 47,71 33 125 695 865
2019-02-05 2019-02-01 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units 		A - Award 3 708 13 891 36,42 49,89 185 000 693 022
2019-01-03 2018-12-31 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units 		A - Award 637 9 969 6,83 51,98 33 125 518 176
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 25 336 −0,39 135,15 −13 515 3 424 160
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 25 436 −0,39 135,06 −13 506 3 435 386
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 25 536 −0,39 135,04 −13 504 3 448 381
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 25 636 −0,39 135,03 −13 503 3 461 629
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 25 736 −0,39 135,01 −13 501 3 474 617
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 25 836 −0,39 134,50 −13 450 3 474 942
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −200 25 936 −0,77 134,49 −26 898 3 488 133
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 26 136 −0,38 134,46 −13 446 3 514 377
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 26 236 −0,38 134,36 −13 436 3 525 200
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 26 336 −0,38 134,19 −13 419 3 534 028
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Stock Options (Right to Buy) 		M - Exercise −4 540 0 −100,00
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 26 436 −0,38 134,16 −13 416 3 546 654
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 26 536 −0,38 134,11 −13 411 3 558 743
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 26 636 −0,37 134,10 −13 410 3 571 888
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 26 736 −0,37 134,06 −13 406 3 584 228
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −200 26 836 −0,74 134,05 −26 810 3 597 366
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 27 036 −0,37 134,04 −13 404 3 623 905
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 27 136 −0,37 134,03 −13 403 3 637 038
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −300 27 236 −1,09 134,00 −40 200 3 649 624
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 27 536 −0,36 133,99 −13 399 3 689 549
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 27 636 −0,36 133,98 −13 398 3 702 671
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −2 27 736 −0,01 133,95 −268 3 715 237
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −2 27 738 −0,01 133,94 −268 3 715 228
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −102 27 740 −0,37 133,93 −13 661 3 715 218
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −2 27 842 −0,01 133,92 −268 3 728 601
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 27 844 −0,36 133,91 −13 391 3 728 590
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −202 27 944 −0,72 133,90 −27 048 3 741 702
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −3 28 146 −0,01 133,89 −402 3 768 468
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −103 28 149 −0,36 133,88 −13 790 3 768 588
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −224 28 252 −0,79 133,87 −29 987 3 782 095
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 28 476 −0,35 133,81 −13 381 3 810 374
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 28 576 −0,35 133,68 −13 368 3 820 040
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 28 676 −0,35 133,63 −13 363 3 831 974
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 28 776 −0,35 133,61 −13 361 3 844 761
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −400 28 876 −1,37 133,46 −53 384 3 853 791
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 29 276 −0,34 133,45 −13 345 3 906 882
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −200 29 376 −0,68 133,28 −26 656 3 915 233
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −200 29 576 −0,67 133,21 −26 642 3 939 819
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 29 776 −0,33 133,16 −13 316 3 964 972
2018-12-06 2018-12-04 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		M - Exercise 4 540 29 876 17,92 33,93 154 042 1 013 693
2018-10-02 2018-09-30 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units 		A - Award 534 9 332 6,06 62,08 33 125 579 300
2018-07-03 2018-06-30 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units 		A - Award 583 8 798 7,10 55,34 32 286 486 877
2018-05-15 2018-05-14 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		A - Award 746 25 336 3,03
2018-05-15 2018-05-14 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		A - Award 2 004 24 590 8,87
2018-04-03 2018-03-31 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units 		A - Award 484 8 153 6,31 63,25 30 625 515 653
2018-02-05 2018-02-01 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units 		A - Award 2 946 7 668 62,38 62,80 185 000 481 577
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −100 22 586 −0,44 110,55 −11 055 2 496 882
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −100 22 686 −0,44 110,50 −11 050 2 506 803
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −100 22 786 −0,44 110,43 −11 043 2 516 258
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −100 22 886 −0,44 110,42 −11 042 2 526 958
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −9 22 986 −0,04 110,41 −994 2 537 884
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −91 22 995 −0,39 110,39 −10 045 2 538 418
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −100 23 086 −0,43 110,38 −11 038 2 548 348
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −200 23 186 −0,86 110,37 −22 074 2 559 039
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −100 23 386 −0,43 110,36 −11 036 2 580 879
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −100 23 486 −0,42 110,35 −11 035 2 591 680
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −100 23 586 −0,42 110,30 −11 030 2 601 536
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −100 23 686 −0,42 110,28 −11 028 2 612 092
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −30 23 786 −0,13 110,22 −3 307 2 621 693
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −500 23 816 −2,06 110,19 −55 095 2 624 285
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −279 24 316 −1,13 110,16 −30 735 2 678 651
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −300 24 595 −1,21 110,15 −33 045 2 709 139
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −100 24 895 −0,40 110,14 −11 014 2 741 935
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −300 24 995 −1,19 110,12 −33 036 2 752 449
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −400 25 295 −1,56 110,11 −44 044 2 785 232
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −7 25 695 −0,03 110,10 −771 2 829 148
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −93 25 702 −0,36 110,09 −10 238 2 829 533
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −200 25 795 −0,77 110,08 −22 016 2 839 514
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −200 25 995 −0,76 110,07 −22 014 2 861 270
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Stock Options (Right to Buy) 		M - Exercise −7 740 0 −100,00
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −100 26 195 −0,38 110,04 −11 004 2 882 367
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −212 26 295 −0,80 109,83 −23 284 2 887 980
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −10 26 507 −0,04 109,82 −1 098 2 910 999
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −100 26 517 −0,38 109,80 −10 980 2 911 699
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −200 26 617 −0,75 109,79 −21 958 2 922 280
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −190 26 817 −0,70 109,76 −20 853 2 943 300
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −100 27 007 −0,37 109,74 −10 974 2 963 883
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −100 27 107 −0,37 109,74 −10 974 2 974 722
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −100 27 207 −0,37 109,74 −10 974 2 985 560
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −500 27 307 −1,80 109,73 −54 865 2 996 397
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −200 27 807 −0,71 109,70 −21 940 3 050 428
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −200 28 007 −0,71 109,70 −21 939 3 072 228
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −100 28 207 −0,35 109,68 −10 968 3 093 744
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −100 28 307 −0,35 109,66 −10 966 3 104 146
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −300 28 407 −1,05 109,61 −32 883 3 113 691
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −10 28 707 −0,03 109,60 −1 096 3 146 144
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −90 28 717 −0,31 109,59 −9 863 3 147 096
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −114 28 807 −0,39 109,56 −12 489 3 155 951
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −200 28 921 −0,69 109,52 −21 904 3 167 428
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −100 29 121 −0,34 109,46 −10 946 3 187 730
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −100 29 221 −0,34 109,46 −10 946 3 198 531
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −200 29 321 −0,68 109,45 −21 890 3 209 183
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −5 29 521 −0,02 109,44 −547 3 230 926
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −100 29 526 −0,34 109,34 −10 934 3 228 520
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −300 29 626 −1,00 109,24 −32 772 3 236 344
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −100 29 926 −0,33 109,20 −10 920 3 267 919
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −200 30 026 −0,66 109,18 −21 836 3 278 239
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale X −100 30 226 −0,33 109,12 −10 912 3 298 261
2018-01-03 2018-01-02 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		M - Exercise 7 740 30 326 34,27 40,27 311 690 1 221 228
2018-01-03 2017-12-31 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units 		A - Award 500 4 693 11,92 61,28 30 625 287 567
2017-10-03 2017-09-30 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units 		A - Award 480 4 167 13,03 63,74 30 625 265 590
2017-07-05 2017-06-30 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units 		A - Award 515 3 661 16,38 55,72 28 709 203 982
2017-05-15 2017-05-12 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		A - Award 2 436 22 586 12,09
2017-04-04 2017-03-31 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units 		A - Award 199 3 124 6,81 54,38 10 833 169 882
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Stock Options (Right to Buy) 		M - Exercise −11 990 0 −100,00
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −200 26 885 −0,74 87,77 −17 554 2 359 696
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −197 27 085 −0,72 87,69 −17 275 2 375 084
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −41 27 282 −0,15 87,64 −3 593 2 391 131
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −400 27 323 −1,44 87,64 −35 056 2 394 588
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −19 27 723 −0,07 87,62 −1 665 2 428 951
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −700 27 742 −2,46 87,61 −61 327 2 430 477
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −141 28 442 −0,49 87,60 −12 352 2 491 519
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −40 28 583 −0,14 87,60 −3 504 2 503 728
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 28 623 −0,35 87,58 −8 758 2 506 945
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 28 723 −0,35 87,58 −8 758 2 515 560
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −400 28 823 −1,37 87,56 −35 024 2 523 742
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −30 29 223 −0,10 87,56 −2 627 2 558 620
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −900 29 253 −2,98 87,55 −78 795 2 561 100
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 30 153 −0,33 87,52 −8 752 2 638 991
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −40 30 253 −0,13 87,52 −3 501 2 647 591
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 30 293 −0,33 87,51 −8 751 2 650 940
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 30 393 −0,33 87,50 −8 750 2 659 388
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −300 30 493 −0,97 87,49 −26 247 2 667 833
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −300 30 793 −0,96 87,47 −26 241 2 693 464
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −60 31 093 −0,19 87,46 −5 248 2 719 549
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 31 153 −0,32 87,44 −8 744 2 724 018
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 31 253 −0,32 87,43 −8 743 2 732 450
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 31 353 −0,32 87,39 −8 739 2 739 939
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 31 453 −0,32 87,36 −8 736 2 747 734
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 31 553 −0,32 87,35 −8 735 2 756 155
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 31 653 −0,31 87,32 −8 732 2 763 940
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −200 31 753 −0,63 87,30 −17 460 2 772 037
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 31 953 −0,31 87,30 −8 730 2 789 337
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −87 32 053 −0,27 87,27 −7 592 2 797 265
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		M - Exercise 11 990 32 140 59,50 37,81 453 342 1 215 213
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 20 150 −0,49 88,34 −8 834 1 780 051
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 20 250 −0,49 88,27 −8 827 1 787 468
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 20 350 −0,49 88,23 −8 823 1 795 480
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 20 450 −0,49 88,21 −8 821 1 803 894
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −1 20 550 0,00 88,17 −88 1 811 894
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −200 20 551 −0,96 88,13 −17 626 1 811 160
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 20 751 −0,48 88,12 −8 812 1 828 578
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 20 851 −0,48 88,08 −8 808 1 836 556
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −165 20 951 −0,78 88,06 −14 530 1 844 945
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −300 21 116 −1,40 88,03 −26 409 1 858 841
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 21 416 −0,46 88,02 −8 802 1 885 036
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −2 726 21 516 −11,24 88,00 −239 888 1 893 408
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 24 242 −0,41 87,99 −8 799 2 133 054
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −743 24 342 −2,96 87,98 −65 369 2 141 609
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −200 25 085 −0,79 87,96 −17 592 2 206 477
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 25 285 −0,39 87,95 −8 795 2 223 816
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 25 385 −0,39 87,94 −8 794 2 232 484
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −500 25 485 −1,92 87,94 −43 970 2 241 151
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −200 25 985 −0,76 87,93 −17 586 2 284 861
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −400 26 185 −1,50 87,92 −35 168 2 302 185
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −200 26 585 −0,75 87,91 −17 582 2 337 087
2017-03-02 2017-03-01 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		S - Sale −100 26 785 −0,37 87,78 −8 778 2 351 187
2017-02-23 2017-02-21 4 BMY BRISTOL MYERS SQUIBB CO
Deferred Share Units 		A - Award 2 925 2 925 54,78 160 218 160 218
2017-02-23 3 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value 		794
2017-02-23 3 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value 		794
2016-05-16 2016-05-12 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		A - Award 2 260 20 150 12,63
2015-05-07 2015-05-06 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Stock Options (Right to Buy) 		A - Award 3 140 3 140
2015-05-07 2015-05-06 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		A - Award 1 970 17 890 12,37
2014-05-09 2014-05-07 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Stock Options (Right to Buy) 		A - Award 3 530 3 530
2014-05-09 2014-05-07 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		A - Award 2 720 15 920 20,61
2013-05-10 2013-05-08 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Stock Options (Right to Buy) 		A - Award 4 030 4 030
2013-05-10 2013-05-08 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		A - Award 3 240 13 200 32,53
2012-05-11 2012-05-09 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Stock Options (Right to Buy) 		A - Award 4 540 4 540
2012-05-11 2012-05-09 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		A - Award 4 040 9 960 68,24
2011-05-13 2011-05-11 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Stock Options (Right to Buy) 		A - Award 7 740 7 740
2011-05-13 2011-05-11 4 CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC
Common Stock 		A - Award 2 280 5 920 62,64
2009-11-04 2009-11-03 4 SGP Merck & Co. Inc.
Phantom Stock Unit 		D - Sale to Issuer −65 587 0 −100,00
2009-11-04 2009-11-03 4 SGP Merck & Co. Inc.
Option (right to buy) 		D - Sale to Issuer −264 600 0 −100,00
2009-11-04 2009-11-03 4 SGP Merck & Co. Inc.
Option (right to buy) 		D - Sale to Issuer −260 000 0 −100,00
2009-11-04 2009-11-03 4 SGP Merck & Co. Inc.
Option (right to buy) 		D - Sale to Issuer −250 000 0 −100,00
2009-11-04 2009-11-03 4 SGP Merck & Co. Inc.
Option (right to buy) 		D - Sale to Issuer −345 000 0 −100,00
2009-11-04 2009-11-03 4 SGP Merck & Co. Inc.
Option (right to buy) 		D - Sale to Issuer −250 000 0 −100,00
2009-11-04 2009-11-03 4 SGP Merck & Co. Inc.
Option (right to buy) 		D - Sale to Issuer −350 000 0 −100,00
2009-11-04 2009-11-03 4 SGP Merck & Co. Inc.
Option (right to buy) 		D - Sale to Issuer −240 000 0 −100,00
2009-11-04 2009-11-03 4 SGP Merck & Co. Inc.
Common Shares 		D - Sale to Issuer −6 099 0 −100,00
2009-11-04 2009-11-03 4 SGP Merck & Co. Inc.
Common Shares 		D - Sale to Issuer −104 616 0 −100,00
2005-11-18 2005-11-17 4 SGP SCHERING PLOUGH CORP
Common Shares 		I - Other 5 853 5 853 19,60 114 718 114 718
2003-11-19 2003-11-17 4 SGP SCHERING PLOUGH CORP
Deferred Stock Unit Award 		P - Purchase 65 000 65 000
2003-11-19 2003-11-17 4 SGP SCHERING PLOUGH CORP
Option (right to buy) 		P - Purchase 350 000 350 000
P
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
S
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
A
Bevilgning, tildeling eller andre oppkjøp av verdipapirer fra selskapet (slik som en opsjon)
C
Konvertering av derivat
D
Salg eller overføring av verdipapirer tilbake til selskapet
F
Betaling av utøvelseskurs eller skatteplikt ved å bruke deler av verdipapirer mottat fra selskapet
G
Gave av verdipapirer fra eller til insidere
K
Aksjebytting og lignende sikringsavtaler
M
Øvelse eller konvertering av derivatverdipapir mottatt fra selskapet (for eksempel en opsjon)
V
En transaksjon frivilig rapportert på Skjema 4
J
Annet (med en fotnote som beskriver transaksjonen)